Huebsch L B, Harker L A
West J Med. 1981 Feb;134(2):109-27.
Platelets play an important role in hemostasis, and alterations in platelet function may be the cause of abnormal bleeding in a wide variety of congenital and acquired clinical disorders. Platelet dysfunction may be classified as disorders of (1) substrate connective tissue, (2) adhesion, (3) aggregation and (4) platelet-release reaction. The congenital defects of platelet function, although uncommon, have provided important insights into platelet physiology and pathophysiology and, as a group, are less common, better characterized and more readily classified than the acquired defects. The severity of bleeding resulting from platelet dysfunction varies greatly and is substantially increased when another defect of hemostasis coexists. A disorder of platelet function is suspected on the basis of the history and physical examination and is confirmed by the finding of a prolonged bleeding time in the presence of an adequate number of platelets. A specific diagnosis often requires measurements of the factor VIII and von Willebrand factor complex and other tests of platelet function. Some of these tests may be available only in specialized laboratories. Therapy for bleeding episodes resulting from platelet dysfunction is directed at (1) removing or treating the underlying cause of the platelet disorder; (2) replacing the missing plasma cofactors needed to support normal platelet function (such as by the transfusion of cryoprecipitate in patients with von Willebrand disease, and (3) transfusing functional platelets in the form of platelet concentrates in patients with disorders of intrinsic platelet dysfunction.
血小板在止血过程中发挥着重要作用,血小板功能的改变可能是多种先天性和后天性临床疾病中异常出血的原因。血小板功能障碍可分为以下几类:(1)底物结缔组织疾病;(2)黏附障碍;(3)聚集障碍;(4)血小板释放反应障碍。血小板功能的先天性缺陷虽然不常见,但为血小板生理学和病理生理学提供了重要见解,而且作为一个整体,与后天性缺陷相比,它们不太常见、特征更明确且更容易分类。血小板功能障碍导致的出血严重程度差异很大,当同时存在另一种止血缺陷时,出血严重程度会大幅增加。根据病史和体格检查怀疑存在血小板功能障碍,并在血小板数量充足的情况下通过出血时间延长得以证实。明确诊断通常需要检测因子VIII和血管性血友病因子复合物以及其他血小板功能检测。其中一些检测可能仅在专业实验室进行。针对血小板功能障碍导致的出血发作的治疗方法包括:(1)消除或治疗血小板疾病的潜在病因;(2)补充支持正常血小板功能所需的缺失血浆辅助因子(例如,对血管性血友病患者输注冷沉淀);(3)对存在内在血小板功能障碍的患者输注血小板浓缩物形式的功能性血小板。